Immatics N.V. (IMTX) stock
IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29+0.12 (+1.94%)
Close on Nov 17, 2026Market cap $843.31MP/E –Yield –
Immatics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Immatics's price to book ratio was 1.1× on Jan 31, 2025, against 3.7× a year earlier. Over the last 3 years it ranged from 1.1× to 10.7×, with a median of 3.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 1.1× | −0.3 |
| 2024 | Dec 31, 2024 | 1.5× | −2.2 |
| 2023 | Jul 31, 2023 | 3.7× | −4.1 |
| 2022 | Jan 31, 2022 | 7.8× | −2.5 |
| 2021 | Dec 31, 2021 | 10.2× | – |
See a number that looks wrong?